MCM
EVH icon

Mazama Capital Management’s Evolent Health EVH Stock Holding History

Mazama Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,777
Closed -$35K – 292
2015
Q2 		$35K Buy
+1,777
New +$33.1K 0.01% 232

Other funds holding EVH

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mazama Capital Management's EVH Position: Q3 2015 in Review

Mazama Capital Management sold out of Evolent Health (EVH) in Q3 2015, closing a stake of 1,777 shares — an estimated $35K sold.

Mazama Capital Management first reported a position in EVH in Q2 2015 and held it in 1 quarter. The position peaked at $35K in Q2 2015. 69 funds tracked by Wall St. Rank hold EVH as of Q3 2015.

  • Mazama Capital Management reported no remaining Evolent Health position as of Q3 2015 after selling out during the quarter.
  • Mazama Capital Management sold 1,777 Evolent Health shares in Q3 2015, an estimated $35K.
  • Mazama Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 1 quarter.
  • Mazama Capital Management's Evolent Health position peaked at $35K in Q2 2015.
  • 69 funds tracked by Wall St. Rank held Evolent Health as of Q3 2015.

Based on Mazama Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.